Article Details
Retrieved on: 2024-08-25 07:39:07
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Mersana Therapeutics (NASDAQ:MRSN), characterized by mixed analyst ratings and significant hedge fund activity. It highlights stock market performance, equity securities, and financial metrics like price-to-earnings ratios and shorting, illustrating the company's standing in financial markets, especially on NASDAQ.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here